Many mammalian studies have shown that only l-carnitine has beneficial effects ( Reference Liedtke, Nellis and Whitesell 16 Reference Spasov, Iezhitsa and Pisarev 18 ) , while d-carnitine can interfere with the uptake and transport of l-carnitine ( Reference Vernez 13 , Reference Paulson and Shug 19 ) , and therefore inhibit the -oxidation of FA ( Reference Spasov and Iezhitsa 20 , Reference Leichter, Ottem and Hahn 21 ) , which has a hepatotoxic effect ( Reference Arafa 22 )
These lawsuits allege that the drug has caused serious side effects such as pancreatic inflammation, thyroid cancer, kidney failure, and gastrointestinal issues, including stomach paralysis, which Novo Nordisk failed to warn patients about
In 1 year, Found users lost an average of 12% body weight
Though both medications are effective in treating obesity and type 2 diabetes, tirzepatide appears to offer a slight advantage in terms of weight loss and cardiovascular improvements